Fingerprint
Dive into the research topics of 'Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
the NeuroNEXT NN103 BeatMG Study Team
Research output: Contribution to journal › Article › peer-review
51
Scopus
citations